Meeting
2022 ASCO Annual Meeting
Characterization of time to diagnosis indicates shorter interval for screenable versus symptom-driven cancers.
Authors
Vladimir Gainullin
Exact Sciences Corporation, Madison, WI
Vladimir Gainullin , Jing Tong , Yali Li , Mudit Gupta , Braxton Lagerman , Jackie Blank , Paul J. Limburg , Christine Hathaway
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10526)
DOI
10.1200/JCO.2022.40.16_suppl.10526
Abstract #
10526
Poster Bd #
404
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prospective study of a multi-modal blood-based test for colorectal cancer screening.
First Author: Paloma Peinado
Poster
2023 ASCO Breakthrough
The challenge of colorectal cancer (CRC) screening in low and middle-income countries (LMIC): The Brazilian ten year long experience.
First Author: Victor Filogonio
Poster
2018 Gastrointestinal Cancers Symposium
Results from an institutional universal reflex testing program for MSI/MMR in colorectal cancer.
First Author: Aaron J Franke
Poster
2014 Gastrointestinal Cancers Symposium
Targeted analysis of progressive metabolic perturbations in colorectal cancer in colorectal adenoma: Potential for a serum metabolomics-based colorectal cancer screening test.
First Author: Farshad Farshidfar